HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infliximab in a child with therapy-resistant systemic vasculitis.

Abstract
Treatment of systemic vasculitides is usually based on the use of corticosteroids and other immunosuppressive drugs. We describe a 10-year-old girl with systemic vasculitis resistant to immunosuppressive treatment who had a rapid and impressive response to treatment with infliximab.
AuthorsSandra W K de Kort, Marion A J van Rossum, Rebecca ten Cate
JournalClinical rheumatology (Clin Rheumatol) Vol. 25 Issue 5 Pg. 769-71 (Sep 2006) ISSN: 0770-3198 [Print] Germany
PMID16267606 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Child
  • Female
  • Humans
  • Infliximab
  • Polyarteritis Nodosa (drug therapy, pathology)
  • Remission Induction
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: